PL2176282T3 - 8-beta-podstawione 16.alfa.-fluoroestratrieny jako wybiórczo działające estrogeny - Google Patents

8-beta-podstawione 16.alfa.-fluoroestratrieny jako wybiórczo działające estrogeny

Info

Publication number
PL2176282T3
PL2176282T3 PL08775031T PL08775031T PL2176282T3 PL 2176282 T3 PL2176282 T3 PL 2176282T3 PL 08775031 T PL08775031 T PL 08775031T PL 08775031 T PL08775031 T PL 08775031T PL 2176282 T3 PL2176282 T3 PL 2176282T3
Authority
PL
Poland
Prior art keywords
estratrienes
fluoro
beta
alpha
substituted
Prior art date
Application number
PL08775031T
Other languages
English (en)
Inventor
Olaf Peters
Nico Braeuer
Ina Thieme
Katja Prelle
Hans-Peter Muhn
Karl-Heinrich Fritzemeier
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of PL2176282T3 publication Critical patent/PL2176282T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0062—Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Neurology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL08775031T 2007-07-12 2008-07-11 8-beta-podstawione 16.alfa.-fluoroestratrieny jako wybiórczo działające estrogeny PL2176282T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07075600A EP2014672A1 (en) 2007-07-12 2007-07-12 8-beta-substituted estratrienes as selectively active estrogens
EP08775031A EP2176282B1 (en) 2007-07-12 2008-07-11 8-beta-substituted 16.alpha.-fluoro-estratrienes as selectively active estrogens
PCT/EP2008/059115 WO2009007454A2 (en) 2007-07-12 2008-07-11 8-beta-substituted estratrienes as selectively active estrogens

Publications (1)

Publication Number Publication Date
PL2176282T3 true PL2176282T3 (pl) 2013-06-28

Family

ID=38657613

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08775031T PL2176282T3 (pl) 2007-07-12 2008-07-11 8-beta-podstawione 16.alfa.-fluoroestratrieny jako wybiórczo działające estrogeny

Country Status (34)

Country Link
US (1) US20090029957A1 (pl)
EP (2) EP2014672A1 (pl)
JP (1) JP2010533152A (pl)
KR (1) KR20100037593A (pl)
CN (1) CN101687902B (pl)
AR (1) AR067507A1 (pl)
AU (1) AU2008274198A1 (pl)
BR (1) BRPI0814207A2 (pl)
CA (1) CA2692727A1 (pl)
CL (1) CL2008002027A1 (pl)
CO (1) CO6270230A2 (pl)
CR (1) CR11211A (pl)
CU (1) CU23885B1 (pl)
CY (1) CY1113351T1 (pl)
DK (1) DK2176282T3 (pl)
DO (1) DOP2010000017A (pl)
EA (1) EA017124B1 (pl)
EC (1) ECSP109872A (pl)
ES (1) ES2393942T3 (pl)
HN (1) HN2010000081A (pl)
HR (1) HRP20120952T1 (pl)
MA (1) MA31565B1 (pl)
NZ (1) NZ582490A (pl)
PA (1) PA8789401A1 (pl)
PE (1) PE20090825A1 (pl)
PL (1) PL2176282T3 (pl)
PT (1) PT2176282E (pl)
RS (1) RS52541B (pl)
SI (1) SI2176282T1 (pl)
TN (1) TN2010000007A1 (pl)
TW (1) TW200911824A (pl)
UA (1) UA99918C2 (pl)
UY (1) UY31220A1 (pl)
WO (1) WO2009007454A2 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012129673A1 (en) * 2011-03-25 2012-10-04 Universite Laval INHIBITORS OF 17ß-HSD1, 17ß-HSD3 AND 17ß-HSD10
US10744439B2 (en) * 2016-06-24 2020-08-18 K&N Engineering, Inc. Compound air filter and method of removing airborne molecular contaminants and volatile organic compounds therefrom
USD905747S1 (en) 2018-04-09 2020-12-22 Mitsubishi Electric Corporation Display screen with animated graphical user interface

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK14632002A3 (sk) * 2000-04-12 2003-03-04 Schering Aktiengesellschaft Substituované estratriény a ich použitie ako selektívne účinných estrogénov
DE10019167A1 (de) * 2000-04-12 2001-10-18 Schering Ag Substituierte Estratriene als selektiv wirksame Estrogene

Also Published As

Publication number Publication date
HN2010000081A (es) 2013-07-01
HRP20120952T1 (hr) 2012-12-31
TW200911824A (en) 2009-03-16
CR11211A (es) 2010-04-27
SI2176282T1 (sl) 2013-02-28
MA31565B1 (fr) 2010-08-02
CA2692727A1 (en) 2009-01-15
WO2009007454A3 (en) 2009-03-05
CU20100008A7 (es) 2011-05-27
DK2176282T3 (da) 2012-12-03
EA201000097A1 (ru) 2010-08-30
UA99918C2 (ru) 2012-10-25
BRPI0814207A2 (pt) 2015-01-27
US20090029957A1 (en) 2009-01-29
AR067507A1 (es) 2009-10-14
CN101687902A (zh) 2010-03-31
CY1113351T1 (el) 2016-06-22
UY31220A1 (es) 2009-03-02
JP2010533152A (ja) 2010-10-21
RS52541B (sr) 2013-04-30
CL2008002027A1 (es) 2009-01-16
AU2008274198A1 (en) 2009-01-15
ECSP109872A (es) 2010-02-26
CO6270230A2 (es) 2011-04-20
WO2009007454A2 (en) 2009-01-15
EP2176282A2 (en) 2010-04-21
CU23885B1 (es) 2013-04-19
CN101687902B (zh) 2013-07-24
NZ582490A (en) 2012-03-30
PT2176282E (pt) 2012-11-30
ES2393942T3 (es) 2013-01-02
EP2014672A1 (en) 2009-01-14
PA8789401A1 (es) 2009-04-23
KR20100037593A (ko) 2010-04-09
TN2010000007A1 (en) 2011-09-26
EP2176282B1 (en) 2012-08-22
PE20090825A1 (es) 2009-07-25
EA017124B1 (ru) 2012-10-30
DOP2010000017A (es) 2010-01-31

Similar Documents

Publication Publication Date Title
IL205880A0 (en) Aminoglycoside analogs, compositions comprising the same and uses thereof
SI2217578T1 (sl) (1,2,4)triazolo(1,5-a)piridinske in (1,2,4)triazolo(1,5-c)pirimidinske spojine in njihova uporaba
IL183740A0 (en) Cyclohexylamides as dopamine d3, d2 and
PL1948770T3 (pl) Kompozycja
IL225694A0 (en) Compounds 6,5- dihydro-h1-pyridine-2-one
IL207639A0 (en) Pyrrolopyrimidinecarboxamide compounds, compositions comprising the same and uses thereof
IL206419A0 (en) 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use
PT2176282E (pt) Estratrienos 8-beta substituídos como estrogénios selectivamente activos
GB0601471D0 (en) The cardioprotector
EP2003102A4 (en) COMPOSTER
IL194972A0 (en) 2-alkoxy-3,4,5-trihydroxy-alkylamide-
GB0625182D0 (en) Supplementary patent to 0624018.8 Claims 1a,2,3,4 & 5
GB0719111D0 (en) T.m.2
ৰাভা et al. ৰাভামিজ
Boroujerdi al-Mustanīrūn al-Irānīyūn wū al-gharb
PL383280A1 (pl) Układ do sterowania urządzeń połączonych w sieć, sposób sterowania poprzez otwartą magistralę typu Feldbus urządzeń połączonych w sieć za pomocą magistrali oraz łącznik sterowany przez układ
GB0602141D0 (en) The turboramjet
IL172976A0 (en) C.i. armwrestling
GB0720590D0 (en) T.m.3
GB0723127D0 (en) T.m.5
GB0808811D0 (en) Algabe 2.1
PL381338A1 (pl) Kalibrator wytłaczarski
GB0618975D0 (en) Reducing . W.I.B.M.S.M.C.C/FC & like
GB0526628D0 (en) C.I. Max
PL384214A1 (pl) Drzwi, zwłaszcza do więzień i aresztów